undamentalytics Newsletter
Sign in

Cryo Cell International Inc income statement

In fiscal 2025, Cryo Cell International Inc reported revenue of $31.6m, down 1.3% on the year before, operating income of $482,394 (a 1.5% margin) and net income of −$2.4m, or −$0.30 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Nov 20102011Nov 20112012Nov 20122013Nov 20132014Nov 20142015Nov 20152016Nov 20162017Nov 20172018Nov 20182019Nov 20192020Nov 20202021Nov 20212022Nov 20222023Nov 20232024Nov 20242025Nov 2025LTMAug 2026
Revenue1818181920212325293231293031323231
Cost of revenue———————791010998877
Gross profit———————19212221202223242424
Research and development00000000000001100
Selling, general and administrative912141112121513161514151617191819
Operating income3−0−22230555844−12300
Interest expense11111111222121222
Income before tax2−2−4011−2443533−133−2−2
Income tax−20200−7−1141111−4200
Net income3−2−6018−12−12423−100−2−2
Diluted EPS$0.29−$0.18−$0.56$0.00$0.05$0.83−$0.16$0.30−$0.11$0.27$0.45$0.25$0.33−$1.14$0.05−$0.30−$0.24
Diluted shares (average)12m12m11m11m10m10m8m8m7m8m8m8m8m8m8m8m8m
EBITDA40−22231565856−11411

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AMS vs CCELCCEL vs HAOAHG vs CCEL

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Cryo Cell International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cryo Cell International Inc.